Diagnosis of tuberculosis in adults and children

Shazia M. Jamil, Eyal Oren, Garth W. Garrison, Sathvik Srikanth, David Lewinsohn, Kevin C. Wilson, Carey C. Thomson

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Evidence-based guidelines on the diagnosis and classification of tuberculosis (TB) in adults and children were prepared by a joint task force of the American Thoracic Society (ATS), the Centers for Disease Control and Prevention (CDC), and the Infectious Disease Society of America (IDSA) (1). The task force employed a multidisciplinary committee to develop clinical recommendations based on the following considerations: the balance of desirable consequences vs. undesirable consequences (harms, cost, and resource use), quality of evidence, patient preferences, and feasibility. The recommendations are based on systemic evidence syntheses or, when published evidence was unavailable, the collective clinical experience of the committee. This summary is prepared for practicing clinicians. TB continues to be one of the major causes of morbidity and mortality in the world because of the continued presence of a large reservoir of individuals with latent TB and the increasing emergence of drug-resistant TB. These guidelines target clinicians in high-resource countries in which there is a low incidence of TB disease and latent TB, such as the United States. World Health Organization guidance may be more suitable for countries with medium and high TB incidence. Clinicians should use caution and always consider unique individual clinical circumstances such as country of birth, history of Bacillus Calmette-Guerin (BCG) vaccination, and immunosuppression when interpreting these recommendations.

Original languageEnglish (US)
Pages (from-to)275-278
Number of pages4
JournalAnnals of the American Thoracic Society
Volume14
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Tuberculosis
Latent Tuberculosis
Advisory Committees
Guidelines
Multidrug-Resistant Tuberculosis
Reproductive History
Patient Preference
Incidence
Centers for Disease Control and Prevention (U.S.)
Mycobacterium bovis
Immunosuppression
Communicable Diseases
Vaccination
Joints
Morbidity
Costs and Cost Analysis
Mortality

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine

Cite this

Jamil, S. M., Oren, E., Garrison, G. W., Srikanth, S., Lewinsohn, D., Wilson, K. C., & Thomson, C. C. (2017). Diagnosis of tuberculosis in adults and children. Annals of the American Thoracic Society, 14(2), 275-278. https://doi.org/10.1513/AnnalsATS.201608-636CME

Diagnosis of tuberculosis in adults and children. / Jamil, Shazia M.; Oren, Eyal; Garrison, Garth W.; Srikanth, Sathvik; Lewinsohn, David; Wilson, Kevin C.; Thomson, Carey C.

In: Annals of the American Thoracic Society, Vol. 14, No. 2, 01.02.2017, p. 275-278.

Research output: Contribution to journalReview article

Jamil, SM, Oren, E, Garrison, GW, Srikanth, S, Lewinsohn, D, Wilson, KC & Thomson, CC 2017, 'Diagnosis of tuberculosis in adults and children', Annals of the American Thoracic Society, vol. 14, no. 2, pp. 275-278. https://doi.org/10.1513/AnnalsATS.201608-636CME
Jamil, Shazia M. ; Oren, Eyal ; Garrison, Garth W. ; Srikanth, Sathvik ; Lewinsohn, David ; Wilson, Kevin C. ; Thomson, Carey C. / Diagnosis of tuberculosis in adults and children. In: Annals of the American Thoracic Society. 2017 ; Vol. 14, No. 2. pp. 275-278.
@article{bfdcff597c2744519c74b83e528b9641,
title = "Diagnosis of tuberculosis in adults and children",
abstract = "Evidence-based guidelines on the diagnosis and classification of tuberculosis (TB) in adults and children were prepared by a joint task force of the American Thoracic Society (ATS), the Centers for Disease Control and Prevention (CDC), and the Infectious Disease Society of America (IDSA) (1). The task force employed a multidisciplinary committee to develop clinical recommendations based on the following considerations: the balance of desirable consequences vs. undesirable consequences (harms, cost, and resource use), quality of evidence, patient preferences, and feasibility. The recommendations are based on systemic evidence syntheses or, when published evidence was unavailable, the collective clinical experience of the committee. This summary is prepared for practicing clinicians. TB continues to be one of the major causes of morbidity and mortality in the world because of the continued presence of a large reservoir of individuals with latent TB and the increasing emergence of drug-resistant TB. These guidelines target clinicians in high-resource countries in which there is a low incidence of TB disease and latent TB, such as the United States. World Health Organization guidance may be more suitable for countries with medium and high TB incidence. Clinicians should use caution and always consider unique individual clinical circumstances such as country of birth, history of Bacillus Calmette-Guerin (BCG) vaccination, and immunosuppression when interpreting these recommendations.",
author = "Jamil, {Shazia M.} and Eyal Oren and Garrison, {Garth W.} and Sathvik Srikanth and David Lewinsohn and Wilson, {Kevin C.} and Thomson, {Carey C.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1513/AnnalsATS.201608-636CME",
language = "English (US)",
volume = "14",
pages = "275--278",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Diagnosis of tuberculosis in adults and children

AU - Jamil, Shazia M.

AU - Oren, Eyal

AU - Garrison, Garth W.

AU - Srikanth, Sathvik

AU - Lewinsohn, David

AU - Wilson, Kevin C.

AU - Thomson, Carey C.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Evidence-based guidelines on the diagnosis and classification of tuberculosis (TB) in adults and children were prepared by a joint task force of the American Thoracic Society (ATS), the Centers for Disease Control and Prevention (CDC), and the Infectious Disease Society of America (IDSA) (1). The task force employed a multidisciplinary committee to develop clinical recommendations based on the following considerations: the balance of desirable consequences vs. undesirable consequences (harms, cost, and resource use), quality of evidence, patient preferences, and feasibility. The recommendations are based on systemic evidence syntheses or, when published evidence was unavailable, the collective clinical experience of the committee. This summary is prepared for practicing clinicians. TB continues to be one of the major causes of morbidity and mortality in the world because of the continued presence of a large reservoir of individuals with latent TB and the increasing emergence of drug-resistant TB. These guidelines target clinicians in high-resource countries in which there is a low incidence of TB disease and latent TB, such as the United States. World Health Organization guidance may be more suitable for countries with medium and high TB incidence. Clinicians should use caution and always consider unique individual clinical circumstances such as country of birth, history of Bacillus Calmette-Guerin (BCG) vaccination, and immunosuppression when interpreting these recommendations.

AB - Evidence-based guidelines on the diagnosis and classification of tuberculosis (TB) in adults and children were prepared by a joint task force of the American Thoracic Society (ATS), the Centers for Disease Control and Prevention (CDC), and the Infectious Disease Society of America (IDSA) (1). The task force employed a multidisciplinary committee to develop clinical recommendations based on the following considerations: the balance of desirable consequences vs. undesirable consequences (harms, cost, and resource use), quality of evidence, patient preferences, and feasibility. The recommendations are based on systemic evidence syntheses or, when published evidence was unavailable, the collective clinical experience of the committee. This summary is prepared for practicing clinicians. TB continues to be one of the major causes of morbidity and mortality in the world because of the continued presence of a large reservoir of individuals with latent TB and the increasing emergence of drug-resistant TB. These guidelines target clinicians in high-resource countries in which there is a low incidence of TB disease and latent TB, such as the United States. World Health Organization guidance may be more suitable for countries with medium and high TB incidence. Clinicians should use caution and always consider unique individual clinical circumstances such as country of birth, history of Bacillus Calmette-Guerin (BCG) vaccination, and immunosuppression when interpreting these recommendations.

UR - http://www.scopus.com/inward/record.url?scp=85014753939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014753939&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201608-636CME

DO - 10.1513/AnnalsATS.201608-636CME

M3 - Review article

C2 - 28146376

AN - SCOPUS:85014753939

VL - 14

SP - 275

EP - 278

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 2

ER -